Floatz logo

Sucralose

Chronic Kidney Diseases

Hospices Civils de LyonActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Chronic Kidney Diseases cohort.

Asset / SponsorPhaseRating
DABIGATRAN ETEXILATE
Irina Ermolaeva
Phase 4BB
CEFADROXIL ANHYDROUS
Mayo Clinic
Phase 4BB
Simethicone
Alfredo Di Leo
Phase 4BB
MACROGOLS
Alfredo Di Leo
Phase 4BB
Cephalexin
Mayo Clinic
Phase 4BB

View all 21 →

Same molecule, other indications

Sucralose is also rated in:

Short Bowel SyndromeDormant
BB
Indicative ·
69 / 100
View asset →
Healthy VolunteersDormant
CCC
Indicative ·
53 / 100
View asset →
obesity disorderDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →